Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

Characterisation of proteins extracted from the surface of Salmonella Typhimurium grown under SPI-2-inducing conditions by LC-ESI/MS/MS sequencing.

Sherry AE, Inglis NF, Stevenson A, Fraser-Pitt D, Everest P, Smith DG, Roberts M.

Proteomics. 2011 Feb;11(3):361-70. doi: 10.1002/pmic.200900802.

PMID:
21268266
2.

SpiC is required for secretion of Salmonella Pathogenicity Island 2 type III secretion system proteins.

Yu XJ, Ruiz-Albert J, Unsworth KE, Garvis S, Liu M, Holden DW.

Cell Microbiol. 2002 Aug;4(8):531-40.

PMID:
12174087
3.
4.

Functional characterization of SsaE, a novel chaperone protein of the type III secretion system encoded by Salmonella pathogenicity island 2.

Miki T, Shibagaki Y, Danbara H, Okada N.

J Bacteriol. 2009 Nov;191(22):6843-54. doi: 10.1128/JB.00863-09.

5.

SipA, SopA, SopB, SopD and SopE2 effector proteins of Salmonella enterica serovar Typhimurium are synthesized at late stages of infection in mice.

Giacomodonato MN, Uzzau S, Bacciu D, Caccuri R, Sarnacki SH, Rubino S, Cerquetti MC.

Microbiology. 2007 Apr;153(Pt 4):1221-8.

PMID:
17379731
6.

Intracellular survival of Salmonella enterica serovar Typhi in human macrophages is independent of Salmonella pathogenicity island (SPI)-2.

Forest CG, Ferraro E, Sabbagh SC, Daigle F.

Microbiology. 2010 Dec;156(Pt 12):3689-98. doi: 10.1099/mic.0.041624-0.

PMID:
20817644
8.

pH-dependent secretion of SseB, a product of the SPI-2 type III secretion system of Salmonella typhimurium.

Beuzón CR, Banks G, Deiwick J, Hensel M, Holden DW.

Mol Microbiol. 1999 Aug;33(4):806-16.

11.

Salmonella translocates across an in vitro M cell model independently of SPI-1 and SPI-2.

Martinez-Argudo I, Jepson MA.

Microbiology. 2008 Dec;154(Pt 12):3887-94. doi: 10.1099/mic.0.2008/021162-0.

PMID:
19047755
12.

Salmonella-containing vacuoles display centrifugal movement associated with cell-to-cell transfer in epithelial cells.

Szeto J, Namolovan A, Osborne SE, Coombes BK, Brumell JH.

Infect Immun. 2009 Mar;77(3):996-1007. doi: 10.1128/IAI.01275-08.

14.

Salmonella effectors within a single pathogenicity island are differentially expressed and translocated by separate type III secretion systems.

Knodler LA, Celli J, Hardt WD, Vallance BA, Yip C, Finlay BB.

Mol Microbiol. 2002 Mar;43(5):1089-103.

15.

SopD2 is a novel type III secreted effector of Salmonella typhimurium that targets late endocytic compartments upon delivery into host cells.

Brumell JH, Kujat-Choy S, Brown NF, Vallance BA, Knodler LA, Finlay BB.

Traffic. 2003 Jan;4(1):36-48. Erratum in: Traffic. 2003 May;4(5):353.

16.

Functions of the Salmonella pathogenicity island 2 (SPI-2) type III secretion system effectors.

Figueira R, Holden DW.

Microbiology. 2012 May;158(Pt 5):1147-61. doi: 10.1099/mic.0.058115-0. Review.

PMID:
22422755
17.

N-terminal residues of SipB are required for its surface localization on Salmonella enterica serovar Typhimurium.

Kim HG, Kim BH, Kim JS, Eom JS, Bang IS, Bang SH, Lee IS, Park YK.

Microbiology. 2008 Jan;154(Pt 1):207-16. doi: 10.1099/mic.0.2007/011528-0.

PMID:
18174139
18.

Salmonella pathogenicity island 1 (SPI-1) type III secretion of SopD involves N- and C-terminal signals and direct binding to the InvC ATPase.

Boonyom R, Karavolos MH, Bulmer DM, Khan CM.

Microbiology. 2010 Jun;156(Pt 6):1805-14. doi: 10.1099/mic.0.038117-0.

PMID:
20185511
19.

SseK1 and SseK2 are novel translocated proteins of Salmonella enterica serovar typhimurium.

Kujat Choy SL, Boyle EC, Gal-Mor O, Goode DL, Valdez Y, Vallance BA, Finlay BB.

Infect Immun. 2004 Sep;72(9):5115-25.

20.

Deletion of invH gene in Salmonella enterica serovar Typhimurium limits the secretion of Sip effector proteins.

Pati NB, Vishwakarma V, Jaiswal S, Periaswamy B, Hardt WD, Suar M.

Microbes Infect. 2013 Jan;15(1):66-73. doi: 10.1016/j.micinf.2012.10.014.

PMID:
23159244
Items per page

Supplemental Content

Support Center